Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache Clinical research trials and A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache. A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache clinical trial. Human subjects often receive the most effective healthcare possible for their A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache



A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

For Condition: Episodic Cluster Headache
Status: Completed
Sponsor(s): Winston Laboratories ,
Synopsis: This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - At least 2 year history of episodic cluster headache (meeting IHS criteria) - At least 2 previous episodes - Expected duration of cluster period is at least 6 weeks but not longer than 16 weeks - At least 1 but not more than 8 headaches on each of the 3 days immediately prior to treatment
Total Enrollment: 60

Location and Contact Information:

Overall Study Official:
ScottPhillips,  Study Director,  Winston Laboratories

Neurological Associates of Tucson
Tucson,  Arizona,  85712
United States
 

Department of Neurology Mayo Clinic
Rochester,  Minnesota,  55905
United States
 

Valley Neurological Headache & Research Center
Phoenix,  Arizona,  85020
United States
 

New England Center for Headache, PC
Stamford,  Connecticut,  06902
United States
 

Houston Headache Clinic
Houston,  Texas,  77004
United States
 

Headache Care Center/Clinvest
Springfield,  Missouri,  65804
United States
 

The Neurology and Headache Treatment Center (Innovative Clinical Research)
Alexandria,  Virginia,  22304
United States
 

Henry Ford Hospital Department of Neurology
Detroit,  Michigan,  48202
United States
 

San Francisco Clinical Research Center
San Francisco,  California,  94109
United States
 

Jefferson Headache Center
Philadelphia,  Pennsylvania,  19107
United States
 

Diamond Headache Clinic
Chicago,  Illinois,  60614
United States
 

Neurology and Headache Specialists of Atlanta
Decatur,  Georgia,  30033
United States
 

Cincinnati Headache Clinic
Cincinnati,  Ohio,  45219
United States
 

Dartmouth Hitchcock Medical Center
Lebanon,  New Hampshire,  03756
United States
 

Nashville Neuroscience Center
Nashville,  Tennessee,  37203
United States
 

California Medical Clinic for Headache
Santa Monica,  California,  90404
United States
 

Cleveland Clinic Foundation
Cleveland,  Ohio,  44195
United States
 

Northern California Headache Clinic
Mountain View,  California,  94040
United States
 

The Headache Wellness Center
Greensboro,  North Carolina,  27401
United States
 

New York Headache Center
New York City,  New York,  10021
United States
 

University of Oklahoma
Oklahoma City,  Oklahoma,  73104
United States
 

Mercy Health Research
Chesterfield,  Missouri,  63017
United States
 

Neurology Clinical Research, Inc.
Plantation,  Florida,  33324
United States
 

Boston Clinical Research Center
Wellesley Hills,  Massachusetts,  02481
United States
 

Neurological Associates of Tulsa, Inc.
Tulsa,  Oklahoma,  74136
United States
 

Michigan Headache Pain & Neurological Institute
Ann Arbor,  Michigan,  48104
United States
 


Additional Information:
Study ID Numbers:
  WL-1001-02-02; 
Study Start Date: January 2002
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00033839

Other Episodic Cluster Headache Studies:
1. A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

2. Intranasal Civamide for Episodic Cluster Headache

Related Studies:

Other Episodic Cluster Headache Clinical Trials
Other North Carolina Clinical Trials
Other Greensboro Clinical Trials

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

Modify your Search

  Other Episodic Cluster Headache Clinical Trials
  Other North Carolina Clinical Trials
  Other Greensboro Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103